Advertisement

Index by author

December 01, 1988; Volume 34,Issue 6

A

  1. Andrews, P R

    1. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;

B

  1. Bean, A J

    1. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

  2. Beart, P M

    1. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;

  3. Bockaert, J

    1. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

  4. Bouhelal, R

    1. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

  5. Bunney, B S

    1. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

  6. Burchell, B

    1. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

  7. Buyukbingol, E

    1. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
      G Klopman and E Buyukbingol
      Molecular Pharmacology December 1988, 34 (6) 852-862;

C

  1. Cory, R

    1. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

  2. Costa, M

    1. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;

  3. Costa, T

    1. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;

  4. Coughtrie, M W

    1. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

D

  1. Dumuis, A

    1. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

E

  1. Eng, W K

    1. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;

  2. Evoniuk, G

    1. Picrate and niflumate block anion modulation of radioligand binding to the gamma-aminobutyric acid/benzodiazepine receptor complex.
      G Evoniuk and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 837-842;

F

  1. Farb, D H

    1. "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;

  2. Farrant, M

    1. "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;

  3. Faucette, L

    1. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;

  4. Forkert, P G

    1. Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;

G

  1. Gelboin, H V

    1. Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;

  2. Gommeren, W

    1. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

  3. Gyenes, M

    1. "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;

H

  1. Herz, A

    1. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;

  2. Highet, R J

    1. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;

  3. Hill, B A

    1. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;

  4. Hokin, L E

    1. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;

  5. Hume, R

    1. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

J

  1. Jacobson, K A

    1. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
      G L Stiles and K A Jacobson
      Molecular Pharmacology December 1988, 34 (6) 724-728;

  2. Jacquez, J A

    1. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;

  3. Janssen, P A

    1. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

  4. Johnson, R K

    1. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;

K

  1. Keen, M

    1. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
      M Keen and S R Nahorski
      Molecular Pharmacology December 1988, 34 (6) 769-778;

  2. Klinz, F J

    1. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;

  3. Klopman, G

    1. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
      G Klopman and E Buyukbingol
      Molecular Pharmacology December 1988, 34 (6) 852-862;

L

  1. Lau, S S

    1. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;

  2. Leakey, J E

    1. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

  3. Levine, L

    1. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
      L Levine
      Molecular Pharmacology December 1988, 34 (6) 793-799;

  4. Leysen, J E

    1. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

M

  1. Manallack, D T

    1. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;

  2. Marvizón, J C

    1. Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites.
      J C Marvizón and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 806-813;

  3. Miller, R J

    1. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
      M W Walker and R J Miller
      Molecular Pharmacology December 1988, 34 (6) 779-792;

  4. Mirehouse-Brown, P

    1. Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;

  5. Monks, T J

    1. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;

N

  1. Nahorski, S R

    1. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
      M Keen and S R Nahorski
      Molecular Pharmacology December 1988, 34 (6) 769-778;

  2. Nen, W

    1. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;

  3. Nestler, E J

    1. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

  4. Neubig, R R

    1. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;

P

  1. Park, S S

    1. Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;

  2. Pauwels, P J

    1. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

R

  1. Ramkumar, V

    1. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
      V Ramkumar and G L Stiles
      Molecular Pharmacology December 1988, 34 (6) 761-768;

  2. Reichman, M

    1. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;

  3. Roth, R H

    1. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

S

  1. Schmalzing, G

    1. The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes.
      G Schmalzing
      Molecular Pharmacology December 1988, 34 (6) 888-895;

  2. Sebben, M

    1. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

  3. Shepard, P D

    1. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

  4. Skolnick, P

    1. Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites.
      J C Marvizón and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 806-813;
    2. Picrate and niflumate block anion modulation of radioligand binding to the gamma-aminobutyric acid/benzodiazepine receptor complex.
      G Evoniuk and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 837-842;

  5. Snyder, S H

    1. Characterization of porphyrin interactions with peripheral type benzodiazepine receptors.
      A Verma and S H Snyder
      Molecular Pharmacology December 1988, 34 (6) 800-805;

  6. Sternglanz, R

    1. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;

  7. Stiles, G L

    1. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
      G L Stiles and K A Jacobson
      Molecular Pharmacology December 1988, 34 (6) 724-728;
    2. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
      V Ramkumar and G L Stiles
      Molecular Pharmacology December 1988, 34 (6) 761-768;

T

  1. Thomsen, W J

    1. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;

V

  1. Vachon, L

    1. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;

  2. Van Lommen, G

    1. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

  3. Verma, A

    1. Characterization of porphyrin interactions with peripheral type benzodiazepine receptors.
      A Verma and S H Snyder
      Molecular Pharmacology December 1988, 34 (6) 800-805;

W

  1. Walker, M W

    1. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
      M W Walker and R J Miller
      Molecular Pharmacology December 1988, 34 (6) 779-792;

  2. Wong, M G

    1. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;
Back to top

In this issue